Status:
UNKNOWN
Assessing LncRNA DQ786243 and IL-17 Expression in Oral Lichen Planus: A Case Control Study
Lead Sponsor:
Cairo University
Conditions:
Patients With Oral Lichen Planus
Eligibility:
All Genders
Brief Summary
Observational case-control study. The current study aims to assess the salivary expression of lncRNA DQ786243 and IL-17 in OLP, to better understand the pathogenesis of OLP and provide effective targe...
Detailed Description
Oral lichen planus (OLP) is a common chronic inflammatory disease associated with cell-mediated immunological dysfunction. OLP can be seen in different clinical presentations. It can be classified as ...
Eligibility Criteria
Inclusion
- Patients diagnosed with OLP.
- Patient who will agree to participate in the study.
- Patients who will accept to sign the informed consent.
Exclusion
- Patients suffering from any systemic disease.
- Patients suffering from any local inflammatory disease or infection.
- Pregnant and lactating women. ▪ Smokers.
Key Trial Info
Start Date :
January 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 29 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04503824
Start Date
January 5 2020
End Date
July 29 2021
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12223